Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400 is registered in ClinicalTrials.gov with John Mascarenhas as lead sponsor.

NCT NCT03065400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03065400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PD-1 Inhibition in Advanced Myeloproliferative Neoplasms
Lead sponsor
John Mascarenhas
Phase
Phase 2
Overall status
Completed
Start date
June 14, 2017
Completion date
May 28, 2020
Enrollment
10 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic phase myelofibrosis, polycythemia vera, post-essential thrombocythemia myelofibrosis, primary myelofibrosis